ArticleCell death discovery2024

MCL1 inhibition: a promising approach to augment the efficacy of sorafenib in NSCLC through ferroptosis induction.

Chao-Yuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.